Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomised and cross-over study in healthy volunteers

Trial Profile

Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomised and cross-over study in healthy volunteers

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Apr 2013

At a glance

  • Drugs Moxifloxacin (Primary)
  • Indications Acute exacerbations of chronic bronchitis; Acute sinusitis; Bacterial infections; Community-acquired pneumonia; Intra-abdominal infections; Pelvic inflammatory disorders; Respiratory tract infections; Skin and soft tissue infections; Tuberculosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 30 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top